Loading Events

« All Events

  • This event has passed.

BioForum – Advancements in targeted drug delivery: Exploring nasal, pulmonary, ophthalmic and dermal systems – SOLD OUT

December 3, 2024 @ 8:45 am - 12:00 pm AEDT

SOLD OUT – Join the waitlist.

Join us for an in-depth exploration of the critical role of drug delivery systems, focusing on the nasal, pulmonary, ocular, and dermal routes. These advances in delivery methods are reshaping modern therapeutics by providing significant advantages over traditional oral or intravenous methods, including enhanced patient compliance, targeted treatment, and improved bioavailability.

The seminar highlights how these systems are revolutionising the landscape of personalised medicine to reduce invasiveness and improve treatment precision. By expanding therapeutic options and boosting patient outcomes, these innovative routes are at the forefront of drug formulation advancements.


Be informed about:

  1. Pulmonary Drug Delivery

Targeting the lungs directly allows for lower doses, reducing side effects and maximizing therapeutic impact, particularly for respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Additionally, pulmonary delivery holds potential for treating systemic diseases due to the large surface area and high permeability of the alveolar region, allowing for rapid absorption in the bloodstream

  1. Nasal Drug Delivery

Nasal route can be used for both local and systemic drug delivery. The nasal route is being explored for central nervous system conditions, like epilepsy, Alzheimer’s, etc. Nasal delivery also supports self-administration and rapid absorption through the nasal mucosa, making it crucial for conditions requiring immediate therapeutic effects, such as migraines and certain emergency medications

  1. Ophthalmic Drug Delivery

The eye is a delicate organ that requires targeted approaches to address conditions such as glaucoma, dry eye and retinal diseases. Preservatives in eye drops affect the retinal surface especially on long term usage. Preservative free delivery systems can help eliminate preservatives from formulations thereby reducing these side effect

  1. Dermal Drug Delivery

The skin provides an accessible and non-invasive route for systemic or localized drug delivery. This route is highly suitable for drugs that are poorly absorbed orally or prone to degradation in the digestive tract


What to expect:

  • The latest updates from industry experts
  • Engaging information for diverse audiences
  • Dynamic panel Q&A session
  • In-person networking opportunities with peers.

Who should attend?

  • Professionals in R&D, focusing on innovation and advancement within biotech and healthtech sectors.
  • Senior leaders overseeing CMC (Chemistry, Manufacturing, and Controls) who are pivotal in transitioning products from development to manufacturing.
  • Product Development leaders and experts driving the strategic and technical development of new therapies and technologies.
  • Analytical professionals in testing, validation, and quality control throughout the product lifecycle.
  • Project, Product, Formulation, and Process Development specialists involved in the end-to-end planning and execution of biopharma projects.
  • Business and Pharmaceutical Development professionals focused on advancing commercially viability and market readiness of new products.
  • Packaging Engineers and Specialists working to ensure safe, compliant, and sustainable product packaging solutions.

Event details:

Date: Tuesday 3 December 2024
Time (AEDT):
8:45 am: Guest arrival and registration
9:00 am: Networking tea and coffee
9:30 am: Welcome and opening remarks
9:35 am: Presentations and Q&A
10:55 am: Closing remarks
11:00 am: Networking lunch
12:00 pm: Close
Format: In-person only
Venue: Burke & Wills Suite, Batman’s Hill on Collins, 623 Collins Street, Melbourne 3000, VIC
Speakers:
Shraddha Dangat, Senior Manager, Sales and Service Champion SEA, Aptar Pharma
Pankaj Sonawane, Director, Sales & Customer Service, India and SEA, Aptar Pharma
Dr Shadab Haque, Senior Research Scientist – Biologics, Medicines Manufacturing Innovation Centre
Dr Grant Mclachlan PhD, Director, CMC Program Management, ENA Respiratory
Host: Karen Parr, CEO, BioMelbourne Network


Registration:

Free to attend for Members and Non Members, registration is essential.

Unsure if your organisation is a member? Check our member directory.


Sponsored by Aptar Pharma

 

 

Details

Date:
December 3, 2024
Time:
8:45 am - 12:00 pm
Event Category:

Contact

BioMelbourne Network
Phone:
+61 3 9667 8181
Email:
info@biomelbourne.org

Home

News & opinion

Member Directory

Events